Alain Huriez

Alain Huriez is a seasoned professional in the Life Sciences sector, currently serving as a Venture Partner at Advent Life Sciences since January 2022. He has an extensive background, bringing over 32 years of experience to the field.

Career Overview

• Early Career: Alain began his professional journey in the mid-1980s as the head of the emergency room at a large teaching hospital in France. He practiced as a General Practitioner for four years before transitioning into the biotechnology sector.

• Biotechnology Experience: He spent 12 years at Quintiles (now IQVIA) as Vice President of Biotechnology in Europe, focusing on drug development and regulatory strategies. Following this, he became an entrepreneur, co-founding several biotechnology companies and serving as CEO of Neovacs and TcLand.

• Leadership Roles: Alain has held various leadership positions, including:

  • Chairman and Managing Partner at AdBio Partners since November 2015.
  • President of Fondation Albert Gleizes since November 2006.
  • Chairman of the Board at Orphalan from March 2015 to August 2022.

• Founding EPEMED: He is also known for founding and chairing the European Personalized Medicine Association (EPEMED), emphasizing his commitment to precision medicine.

Contributions to Advent Life Sciences

Alain joined Advent Life Sciences in 2012 and later founded AdBio Partners in 2016, where he manages early-stage life sciences seed funds. His role involves identifying promising investment opportunities within the biotechnology landscape.

Through his extensive career, Alain Huriez has significantly impacted the biotechnology sector, particularly in Europe, by fostering innovation and supporting new ventures.